MedPath

Clinical study of modified Guipi decoction in improving cognitive function of children with cblC methylmalonic aciduria

Phase 1
Recruiting
Conditions
Methylmalonic aciduria
Registration Number
ITMCTR2100005327
Lead Sponsor
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.The diagnosis of MMA was consistent with cblC type of deficiency of both heart and spleen;
2.With complications of cognitive impairment, (WISC-IV) scale score IQ below 90;
3.The age ranged from 1 to 6 years old;
4.The legal guardian of the child signed the informed consent and was willing to accept traditional Chinese medicine treatment and clinical investigation.

Exclusion Criteria

1.Patients with severe visual impairment, hearing impairment and cardiovascular and cerebrovascular diseases were present;
2.Patients with other diseases that seriously affect cognitive function, such as hypothyroidism and hydrocephalus;
3.Patients with severe infection, abnormal liver and kidney function and metabolic disorder.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.